© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, VolitionRx Limited (VNRX) shows an Average True Range (ATR) of 0.03 and an Enterprise Value of 50.78M. Its average trading volume over the past 3 months is 1.58M, indicating liquidity. These fundamental metrics provide insight into VNRX's underlying financial health and market activity.
VolitionRx Limited (VNRX) technical indicators as of December 22, 2025: the SMA 20 is -11.48%, SMA 50 at -29.29%, and SMA 200 at -52.95%. The RSI 14 value is 35.13, suggesting its current momentum. These technical analysis signals help assess VNRX's price trends and potential future movements.
VolitionRx Limited (VNRX) stock performance overview as of December 22, 2025: The 52-week high is $0.94 (currently -72.77% below), and the 52-week low is $0.234 (currently 9.64% above). Over the past year, VNRX's performance is -54.69%, compared to the S&P 500's 12.87% change.
According to market data, VolitionRx Limited (VNRX) stock's recent performance metrics show that over the last month, VNRX is -26.86%, with a Year-to-Date (YTD) performance of -57.33%. Over the past year, the stock has seen a -54.69% change. These figures summarize VNRX's price movements across various periods, reflecting its historical returns.
According to current financial data, VNRX stock's P/E (TTM) ratio is -1.21, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for VNRX, including P/S (17.34), P/B (-1.13), and P/FCF (-1.28), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.